2025-03-25T10:21:23Z
2025-03-25T10:21:23Z
2024
Despite its benefits for tumour detection and treatment, the administration of contrast agents in dynamic contrast-enhanced MRI (DCE-MRI) is associated with a range of issues, including their invasiveness, bioaccu- mulation, and a risk of nephrogenic systemic fibrosis. This study explores the feasibility of producing synthetic contrast enhancements by translating pre-contrast T1-weighted fat-saturated breast MRI to their corresponding first DCE-MRI sequence leveraging the capabilities of a generative adversarial network (GAN). Additionally, we introduce a Scaled Aggregate Measure (SAMe) designed for quantitatively evaluating the quality of synthetic data in a principled manner and serving as a basis for selecting the optimal generative model. We assess the generated DCE-MRI data using quantitative image quality metrics and apply them to the downstream task of 3D breast tumour segmentation. Our results highlight the potential of post-contrast DCE-MRI synthesis in enhancing the robustness of breast tumour segmentation models via data augmentation. Our code is available at https://github.com/RichardObi/pre_post_synthesis.
Object of conference
Accepted version
English
Càncer de mama; Aprenentatge automàtic; Substàncies de contrast; Breast cancer; Machine learning; Contrast media (Diagnostic imaging)
SPIE
Versió postprint de la comunicació publicada a: https://doi.org/10.1117/12.3006961
Comunicació a: Proc. SPIE 12926, Medical Imaging 2024: Image Processing, 129260Y (2 April 2024)
Proceedings SPIE
12926
https://doi.org/10.1117/12.3006961
(c) SPIE, 2024